Browsing by Author Cressey T.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 21  next >
Issue DateTitleAuthor(s)
1-Jan-2016A Population Pharmacokinetic/Pharmacodynamic Model Predicts Favorable HDL Cholesterol Changes Over the First 5 Years in Children Treated With Current Efavirenz-Based RegimensHomkham N.; Cressey T.; Ingsrisawang L.; Bouazza N.; Ngampiyaskul C.; Hongsiriwon S.; Srirojana S.; Kanjanavanit S.; Bhakeecheep S.; Coeur S.; Salvadori N.; Treluyer J.; Jourdain G.; Urien S.
1A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: The TARGET studyCressey T.; Siriprakaisil O.; Klinbuayaem V.; Quame-Amaglo J.; Kubiak R.; Sukrakanchana P.; Than-in-at K.; Baeten J.; Sirirungsi W.; Cressey R.; Drain P.
1-Jan-2016A sample size calculation of Bayesian design for superiority trials with rare eventsSripan P.; Ingsrisawang L.; Amzal B.; Le Ccur S.; Cressey T.; Lallemant M.; Urien S.
5Assessment of Nevirapine Prophylactic and Therapeutic Dosing Regimens for NeonatesCressey T.; Punyawudho B.; Le Coeur S.; Jourdain G.; Saenjum C.; Capparelli E.; Jittayanun K.; Phanomcheong S.; Luvira A.; Borkird T.; Puangsombat A.; Aarons L.; Sukrakanchana P.; Urien S.; Lallemant M.; Sangsawang S.; Achalapong J.; Preedisripipat K.; Putiyanun C.; Wanchaitanawong V.; Yuthavisuthi P.; Ngampiyaskul C.; Kanjanavikai P.; Chotivanich N.; Hongsiriwon S.; Suwankornsakul W.; Sreshthatat P.; Kanjanasing A.; Kwanchaipanich R.; Rawangban B.; Santadusit S.; Jarupanich T.; Warachit B.; Siriwachirachai T.; Rojanakarin P.; Vivatpatanakul K.; Hanpinitsak S.; Wanasiri P.; Srirojana S.; Kongpanichkul R.; Bunjongpak S.; Sabsanong P.; Liampongsabuddhi P.; Pongdetudom K.; Khamja P.; Akarathum N.; Phonin S.; Limpitikul W.; Jungpipun J.; Petprakorp R.; Mahattanan S.; Kotchawet S.; Pilalai T.
15-Jan-2012A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapineVan Dyke R.; Ngo-Giang-Huong N.; Shapiro D.; Frenkel L.; Britto P.; Roongpisuthipong A.; Beck I.; Yuthavisuthi P.; Prommas S.; Puthanakit T.; Achalapong J.; Chotivanich N.; Rasri W.; Cressey T.; Maupin R.; Mirochnick M.; Jourdain G.
1-Jan-2016Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir-boosted lopinavir on HIV viral load reduction during pregnancySripan P.; Le Coeur S.; Ingsrisawang L.; Cressey T.; Bouazza N.; Foissac F.; Ngo-Giang-Huong N.; Traisathit P.; Srirompotong U.; Ayudhaya O.; Puangsombat A.; Jungpipun J.; Jittayanun K.; Tréluyer J.; Jourdain G.; Lallemant M.; Urien S.
1-Mar-2012Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartumCressey T.; Stek A.; Capparelli E.; Bowonwatanuwong C.; Prommas S.; Sirivatanapa P.; Yuthavisuthi P.; Neungton C.; Huo Y.; Smith E.; Best B.; Mirochnick M.
15-May-2016Expedient screening for HIV-1 protease inhibitors using a simplified immunochromatographic assayKitidee K.; Khamaikawin W.; Thongkum W.; Tawon Y.; Cressey T.; Jevprasesphant R.; Kasinrerk W.; Tayapiwatana C.
2Incidence of tuberculosis and associated mortality in a cohort of human immunodeficiency virus-infected children initiating antiretroviral therapySalvadori N.; Ngo-Giang-Huong N.; Duclercq C.; Kanjanavanit S.; Ngampiyaskul C.; Techakunakorn P.; Puangsombat A.; Figoni J.; Mary J.; Collins I.; Cressey T.; Coeur S.; Sirirungsi W.; Lallemant M.; McIntosh K.; Jourdain G.
1-Jan-2015No relationship between drug transporter genetic variants and tenofovir plasma concentrations or changes in glomerular filtration rate in HIV-infected adultsSirirungsi W.; Urien S.; Urien S.; Urien S.; Harrison L.; Harrison L.; Kamkon J.; Kamkon J.; Tawon Y.; Tawon Y.; Luekamlung N.; Thongpaen S.; Nilmanat A.; Jourdain G.; Jourdain G.; Jourdain G.; Lallemant M.; Lallemant M.; Lallemant M.; Le Coeur S.; Le Coeur S.; Le Coeur S.; Ngo-Giang-Huong N.; Ngo-Giang-Huong N.; Ngo-Giang-Huong N.; Owen A.; Cressey T.; Cressey T.; Cressey T.
1-Jan-2017Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patientsBouazza N.; Cressey T.; Foissac F.; Bienczak A.; Denti P.; McIlleron H.; Burger D.; Penazzato M.; Lallemant M.; Capparelli E.; Treluyer J.; Urien S.
1-May-2016Optimization of vancomycin dosing regimens to achieve therapeutic targets in critically Ill patients in ThailandDedkaew T.; Cressey T.; Phothirat C.; Chaiwarith R.; Punyawudho B.; Lucksiri A.
1-Oct-2012Pharmacokinetic optimization of antiretroviral therapy in pregnancyBuckoreelall K.; Cressey T.; King J.
10-Sep-2010Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancyCressey T.; Jourdain G.; Rawangban B.; Varadisai S.; Kongpanichkul R.; Sabsanong P.; Yuthavisuthi P.; Chirayus S.; Ngo-Giang-Huong N.; Voramongkol N.; Pattarakulwanich S.; Lallemant M.
1-Apr-2012Pharmacokinetics of nevirapine in HIV and tuberculosis-coinfected children receiving antiretroviral fixed-dose combination tablets while receiving rifampicin-containing tuberculosis treatment and after rifampicin discontinuationPrasitsuebsai W.; Cressey T.; Capparelli E.; Vanprapar N.; Lapphra K.; Chokephaibulkit K.
10-Jun-2016Pharmacokinetics of once-daily darunavir/ ritonavir with and without etravirine in human immunodeficiency virus-infected children, adolescents, and young adultsLarson K.; Cressey T.; Yogev R.; Wiznia A.; Hazra R.; Jean-Philippe P.; Graham B.; Gonzalez A.; Britto P.; Carey V.; Acosta E.
1-Jul-2016Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant WomenTran A.; Best B.; Stek A.; Wang J.; Capparelli E.; Burchett S.; Kreitchmann R.; Rungruengthanakit K.; George K.; Cressey T.; Chakhtoura N.; Smith E.; Shapiro D.; Mirochnick M.; Buschur S.; Jackson C.; Paul M.; McGregor D.; Yogev R.; Kalra R.; Florez C.; Bryan P.; Stone M.; Hull A.; Caffery M.; Spector S.; Wilson J.; Giner J.; Donnelly M.; Cooper E.; McLaud D.; Tucker L.; Hitti J.; Robson-Nuss A.; Melvin A.; Keller M.; Bolaris M.; Hayes J.; Kamer F.; Spencer L.; Homans J.; Metz T.; Wallace J.; Katai A.; Aziz M.; McNichols M.; Schmidt J.; Wara D.; Maka K.; Cohan D.; Deveikis A.; Batra J.; Alvarez J.; Carter M.; Deville J.; Janzen C.; Gutierrez J.; Cavallo M.; Purswani M.; Knapp K.; Sublette N.; Wride T.
28-Nov-2016Pharmacokinetics of unboosted atazanavir in treatment-experienced HIV-infected children, adolescents and young adultsCressey T.; Hazra R.; Wiznia A.; Foca M.; Jean-Philippe P.; Graham B.; King J.; Britto P.; Carey V.; Acosta E.; Yogev R.
1-Oct-2012Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeedingOlagunju A.; Owen A.; Cressey T.
9-Aug-2016Prevention of mother-to-child transmission of hepatitis B virus: A phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigenJourdain G.; Ngo-Giang-Huong N.; Cressey T.; Hua L.; Harrison L.; Tierney C.; Salvadori N.; Decker L.; Traisathit P.; Sirirungsi W.; Khamduang W.; Bowonwatanuwong C.; Puthanakit T.; Siberry G.; Watts D.; Murphy T.; Achalapong J.; Hongsiriwon S.; Klinbuayaem V.; Thongsawat S.; Chung R.; Pol S.; Chotivanich N.